Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

v3.22.0.1
CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Expenses      
Research and development (note 10, 21, 22) $ 12,920,371 $ 12,944,510 $ 10,817,997
Operating (note 10, 21, 22) 13,314,574 12,514,496 9,558,641
Loss before the following (26,234,945) (25,459,006) (20,376,638)
Change in fair value of warrant derivative (note 8) 17,117 3,491,928 (12,608,808)
Foreign exchange loss (note 21) (135,636) (659,173) (316,719)
Interest income, net 98,612 121,194 179,277
Loss before income taxes (26,254,852) (22,505,057) (33,122,888)
Income tax expense (note 15) (49,427) 0 0
Net loss (26,304,279) (22,505,057) (33,122,888)
Other comprehensive loss items that may be reclassified to net loss      
Translation adjustment (12,487) (63,876) (143,403)
Net comprehensive loss $ (26,316,766) $ (22,568,933) $ (33,266,291)
Basic loss per common share (cad per share) $ (0.49) $ (0.56) $ (1.50)
Diluted loss per common share (cad per share) $ (0.49) $ (0.56) $ (1.50)
Weighted average number of shares (basic) (shares) 53,513,225 40,338,789 22,137,990
Weighted average number of shares (diluted) (shares) 53,513,225 40,338,789 22,137,990